CRL: Officer Changes & Compensation Arrangements Reported
Ticker: CRL · Form: 8-K · Filed: Jan 16, 2024 · CIK: 1100682
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**CRL just filed an 8-K about executive changes and pay, keep an eye out for details!**
AI Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed an 8-K on January 16, 2024, reporting an event from January 9, 2024, related to the departure or appointment of officers and their compensatory arrangements. This filing indicates potential changes in leadership or executive compensation, which could impact the company's strategic direction and financial performance. Investors should monitor subsequent filings for details on who departed or was appointed and the specifics of any new compensation packages, as these can influence stock valuation.
Why It Matters
Changes in executive leadership and compensation can signal shifts in company strategy or financial health, directly affecting investor confidence and future stock performance.
Risk Assessment
Risk Level: medium — Without specific names or compensation details, the impact of these changes is uncertain, creating moderate risk for investors.
Analyst Insight
Investors should look for subsequent filings or press releases from CHARLES RIVER LABORATORIES INTERNATIONAL, INC. that provide specific names of executives involved and details of any new compensation agreements to fully assess the impact of these changes.
Key Players & Entities
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — the registrant filing the 8-K
- January 9, 2024 (date) — date of the earliest event reported in the 8-K
- January 16, 2024 (date) — date the 8-K was filed
- 001-15943 (dollar_amount) — Commission File Number for CRL
FAQ
What specific event triggered CHARLES RIVER LABORATORIES INTERNATIONAL, INC. to file this 8-K?
The 8-K was filed due to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' as per the Item Information.
When did the earliest event reported in this 8-K occur?
The earliest event reported in this 8-K occurred on January 9, 2024.
What is the trading symbol for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and on which exchange is it registered?
The trading symbol for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is CRL, and it is registered on the New York Stock Exchange.
What is the business address of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as stated in the filing?
The business address is 251 Ballardvale Street, Wilmington, Massachusetts 01887.
Does this 8-K filing provide specific names of the officers who departed or were appointed, or details of their compensatory arrangements?
No, this specific 8-K filing only indicates the category of the event (Departure/Election/Appointment of Officers; Compensatory Arrangements) but does not provide specific names, roles, or financial details within the provided text.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2024-01-16 16:32:51
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value CRL New York Stock Exchange
Filing Documents
- crl-20240109.htm (8-K) — 23KB
- 0001100682-24-000002.txt ( ) — 145KB
- crl-20240109.xsd (EX-101.SCH) — 2KB
- crl-20240109_lab.xml (EX-101.LAB) — 24KB
- crl-20240109_pre.xml (EX-101.PRE) — 12KB
- crl-20240109_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Date: January 16, 2024 By: /s/ Matthew L. Daniel Matthew L. Daniel, Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer 3